Corrò, Claudia
Buchs, Nicolas C.
Tihy, Matthieu
Durham-Faivre, André
Bichard, Philippe
Frossard, Jean-Louis
Puppa, Giacomo
McKee, Thomas
Roth, Arnaud
Zilli, Thomas
Trembleau, Christelle
Di Marco, Mariagrazia
Dutoit, Valérie
Dietrich, Pierre-Yves
Ris, Frédéric
Koessler, Thibaud
Article History
Received: 6 December 2021
Accepted: 24 June 2022
First Online: 15 July 2022
Declarations
:
: This clinical study (registration number: NCT04109755) has received ethical approval from the Regional Research and Ethics Committee (CCER) and Swissethics (Protocol number: 2018–02346). A written informed consent is obtained from all participants upon participation.
: Not applicable.
: TK discloses consulting or advisory role for MSD, BMS, Lilly, Roche, Boeringer Ingelheim and Servier.TZ declares the following conflict of interests: Honoraria/Travel costs (institutional) — Janssen, Amgen, Ferring, Debiopharm, Bayer, Astellas; Research Grants (institutional) — Varian Medical Systems, Debiopharm; Advisory Boards (institutional) — Janssen.All other authors declare that they have no competing interests.